The largest database of trusted experimental protocols

10 protocols using sulfo nhs acetate

1

Identification of Lysines in Heparin Binding Sites

Check if the same lab product or an alternative is used in the 5 most similar protocols
The identification of lysines in heparin binding sites (HBS) was according to Ori et al. [34 (link)] with minor modifications. A heparin minicolumn was made by placing a plastic air filter at the end of a small pipette tip into which 30 µl of AF-heparin beads (Tosoh Biosciences, Stuttgart, Germany; binding capacity 4 mg antithrombin III ml−1 resin) was packed. A 5 ml syringe was used to pack the minicolumn and dispense buffer. The heparin column was equilibrated four times with 50 µl of PB 150 buffer (17.9 mM Na2HPO4, 2.1 mM NaH2PO4, 150 mM NaCl, pH 7.8). A minimum of 40 µg FGF protein was loaded onto the heparin column, and the loading was repeated three times with the same sample. After binding, the column was washed with PB 150 buffer four times. To acetylate exposed lysines, the minicolumn was then quickly rinsed with 20 µl of PB 150 containing 50 mM sulfo-NHS–acetate (Life Technologies, Paisley, UK) and then incubated for 5 min with 20 µl of fresh PB 150 containing 50 mM sulfo-NHS–acetate at room temperature. After acetylation, the minicolumn was washed with 50 µl of PB 150 buffer, and acetylated protein was eluted from heparin with 2 × 20 µl elution buffer (45 mM Na2HPO4, 5 mM NaH2PO4, 2 M NaCl, pH 7.8).
+ Open protocol
+ Expand
2

Peptide Modification and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peptides were purchased from China Peptide (China) and Synpeptide (China). Both batches were purified to >95% purity by HPLC and validated by mass spectrometry (See Supplementary Data S2 for Synpeptide quality control data). No variation in peptide activity was observed between batches. Each batch was reconstituted in water and the concentration adjusted to 100 µM based on spectroscopy using 41480 (N1) and 35980 (N2) extinction co-efficients. To block the basic charged residues of N1, sulfo-NHS acetate (Thermo Scientific) was reacted with primary amines by incubation of equal masses of peptide and sulfo-NHS acetate in PBS for 1 hour at room temp. Reacted peptides were washed 3 × in 3 kDa cut-off spin columns in PBS, then resuspended in PBS to a final concentration of 100 µM. This reaction produced extensive modification of the peptide (Supplementary Figure S3).
+ Open protocol
+ Expand
3

Chemical Modification of Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemical acetylation was performed with sulfo-NHS-acetate (Thermo Scientific, Rockford, IL) as described [10 (link)]. Succinylation was done with sulfo-NHS-succinate which was prepared as follows. 9.7 mg of sodium succinate, 7.8 mg of NHS, and 9.7 mg of EDC were dissolved in 300 μl of dimethylformamide in a glass vial and incubated at room temperature for 16 hr. From this reaction, 50μl was removed to a new vial, dried under nitrogen, and washed with ether. After re-drying, the material was dissolved in 50 μl of water and incubated immediately with VLCAD protein for 2 hr at room temperature. All acylated proteins were dialyzed overnight prior to experimentation.
+ Open protocol
+ Expand
4

Fluorescent Labeling of α-Synuclein Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Commercial recombinant proteins, including human Tau (R&D Systems, SP-495), α-Syn (Proteos, cat# RP-003), oligomeric α-Syn (StressMarq, cat# SPR-484), α-Syn preformed fibrils (PFFs) (StressMarq, cat# SPR-322-C), α-Syn N (1–60) fragment (rPeptide, cat# S-1011–1), and α-Syn ΔN (61–140) fragment (rPeptide, cat# S-1013–1) were labeled with Alexa Fluor® 488 ester (Life Technologies, cat# A10235) according to the manufacturer’s instructions. After labeling, 100 mM glycine was added to quench the reaction and the proteins were subjected to Amicon Ultra-0.5 mL Centrifugal Filters (Millipore, cat# UFC500396 -3 KDa, cat# UFC501096 -10 KDa, and cat# UFC510096 -100 KDa) to remove any unreacted label. The fluorescently labeled α-Syn PFFs were sonicated using a Qsonica Q125 Sonicator at 30% amplitude for 30 cycles (1 s ON, 1 s OFF) before incubating with cells. Lysine capped proteins were prepared with Sulfo-NHS-Acetate (Thermo, cat# 26777) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
5

Peptide Labeling and Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
NAC N-terminal peptides were ordered from Genscript. Peptides were dissolved to 1 mM in 0.1 M sodium carbonate buffer, pH 8.5. Peptide solutions were added to a 25-fold molar excess of Sulfo-NHS Acetate (Thermo Scientific, Waltham, MA, USA) to amine groups in the sample and incubated for 1 hour at room temperature. Reaction was quenched using a 1 M Tris-HCl, pH 7.5 solution. To quantify the efficiency of this labeling, a lysine standard curve was established; samples were assayed for free primary amines by adding 0.01% (w/v) TNBS in 0.1 M sodium bicarbonate, pH 8.5 solution (G Biosciences) to each sample and standard, and incubated at 37°C for 2 hours. 10% SDS and 1N HCl was then added to stop the reaction. Absorbance was measured at 335 nm.
+ Open protocol
+ Expand
6

Chemical Modification of Beta-Amyloid Peptide

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemical modification of (β15–66)2 to block the
primary amines in lysine side chains was performed using Sulfo-NHS-acetate
(Thermo Scientific) according to manufacturer’s protocol. The modified
(β15–66)2 was dialyzed into HBS (HEPES-buffered
saline with 10 mM HEPES, pH 7.4, and 150 mM NaCl) containing 1 mM
CaCl2 to remove the excess of Sulfo-NHS-acetate. Chemical
modification of arginine residues of (β15–66)2 was
performed using p-Hydroxyphenylglyoxal (Thermo Scientific) according to the
previously described protocol.33
+ Open protocol
+ Expand
7

Acetylation and Cy5-Labeling of Thermolysin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thermolysin from Geobacillus stearothermophilus (Sigma-Aldrich) was acetylated using a 10:1 w/w surplus of sulfo-NHS-acetate (Thermo Fisher Scientific) for half an hour at room temperature in 100 mm triethylammonium bicarbonate (TEAB), pH 8.3. The reaction was quenched with 50 mm Tris-HCl, pH 8, and the acetylated thermolysin was desalted into HBS with 5 mm CaCl2 using a PD-10 column (GE Healthcare).
Cy5-labeled thermolysin was prepared by labeling thermolysin with a 1:1 molar ratio of Cy5 mono NHS ester (GE Healthcare) in 100 mm TEAB, pH 8.3, for half an hour at room temperature. The reaction was quenched with Tris-HCl and the Cy5-labeled thermolysin was desalted as for acetylated thermolysin. Absorbance at 280 nm and 550 nm was used to calculate the labeling ratio, which was an ∼0.6:1 molar ratio of Cy5 to thermolysin. A portion of the Cy5-labeled thermolysin was then acetylated as described for unlabeled thermolysin.
+ Open protocol
+ Expand
8

SDS Stability Assay for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SDS stability assay is based on previously reported assays [35] (link), [36] (link). To 55 µM protein in pH 7 buffer either a 10-fold molar excess of biotin-5-fluorescein or the same volume of pH 7 buffer was added. Due to the high isoelectric point of avidin, A/A2-1, A/A2-B and A/A2-B I109K (pI>9), the proteins (including AVR2, pI = 4) were acetylated by adding a 40-fold molar excess of Sulfo-NHS-acetate (Thermo Scientific) [35] (link). The protein sample was divided into equal aliquots and incubated for 20 min at 20, 40, 50, 60, 70, 80, 90, or 100°C. After incubation, the same volume of 2× sample buffer (60 µM Tris-HCl, pH 6.8, 25% glycerol, 0.01% Bromphenol blue) was added, before loading 5 µg of the protein in a 15% acrylamide-bisacrylamide gel. To detect the bound biotin-5-fluorescein, the gels were analyzed under UV in a Molecular Imager Gel Doc XR+ System (BioRad Laboratories, Hercules, CA, USA), before Coomassie Brilliant Blue staining. As a control, proteins were incubated in denaturizing SDS sample buffer (60 µM Tris-HCl, pH 6.8, 25% glycerol, 2% SDS, 0.01% Bromphenol blue, 0.5% β-mercaptoethanol) for 20 min at 100°C. PageRuler Plus Prestained Ladder (Thermo Scientific) was used as molecular weight marker.
+ Open protocol
+ Expand
9

Thrombin-Binding Aptamer Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Standard solvents and reagents were purchased from either Sigma-Aldrich, Chemgenes or Alfa Aesar. 5′-O-(4,4′-Dimethoxytrityl)-5-(3-trifluoroacetylamino-1-propenyl)-2′-deoxyuridine was purchased from Hongene Biotechnology. 0.5 M (1S)-(+)-(10-Camphorsulfonyl)-oxaziridine (CSO) and biotinTEG phosphoramidite were purchased from Glen Research. Sulfo-NHS-acetate was purchased from ThermoFisher Scientific. Thin layer chromatography was carried out on silica gel 60 F254 from either Selecto Scientific (flexible plates) or Fluka (aluminum plates). Flash chromatography was performed on Fluka silica (230–400 mesh). NMR was performed on either a Varian Inova 500 or Bruker 600 MHz instrument. 1H NMR spectra were referenced to the signal of the solvent, and 31P NMR used 2% phosphoric acid as an external reference. FPLC (fast protein liquid chromatography) and HPLC (high performance liquid chromatography) were performed on an AKTA Basic System from GE Healthcare. The protein used in this investigation was human α-thrombin (Haematologic Technologies). The protein was handled according to the manufacturer's recommendations and aliquots were stored at −80°C. The aptamers were stored at −20°C.
+ Open protocol
+ Expand
10

Purification and Labeling of Anti-hVLDLR Antibody

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse anti-hVLDLR monoclonal antibody mAb 5F328 (link) was purified as described
earlier.29 (link) Goat
secondary anti-mouse polyclonal antibodies conjugated with HRP and HRP substrate
SureBlue TMB were purchased from KPL (Gaithersburg, MD). Thrombin CleanCleave
kit was obtained from Sigma (St. Louis, MO), Blocker BSA in TBS,
sulfo-NHS-acetate, and p-hydroxyphenylglyoxal were from Thermo Scientific
(Rockford, IL).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!